|
Headlines:
|
 |
Back to cancer staging index
Cancer Staging Systems
Staging of Multiple Myeloma
Last Update: Sunday January 4th, 2004 7:15 PM GMT
Stage I multiple myeloma
Stage I multiple myeloma means all of the following:
- Hemoglobin greater than 10 g/dL.
- Normal serum calcium.
- Normal bone structure.
- Low M-protein production as shown by:
- IgG less than 5.0 g/dL.
- IgA less than 3.0 g/dL.
- Urinary κ or λ less than 4 g/24 hours.
Estimated myeloma cell mass: less than 0.6 trillion (1012)/m2
(low burden).
The following subclassification of stages is used:
- Creatinine less than 2.0 mg/dL.
- Creatinine greater than or equal to 2.0 mg/dL.
Impaired renal function worsens prognosis regardless of stage.
Stage II multiple myeloma
Stage II multiple myeloma means multiple myeloma that fits in
neither stage I nor stage III.
Estimated myeloma cell mass: 0.6 to 1.2 trillion (1012)/m2
(intermediate burden).
The following subclassification of stages is used:
- Creatinine less than 2.0 mg/dL.
- Creatinine greater than or equal to 2.0 mg/dL.
Impaired renal function worsens prognosis regardless of stage.
Stage III multiple myeloma
Stage III multiple myeloma means 1 or more of the following:
- Hemoglobin less than 8.5 g/dL.
- Serum calcium greater than 12.0 mg/dL.
- More than 3 lytic bone lesions.
- High M-protein production as shown by:
- IgG greater than 7.0 g/dL.
- IgA greater than 5.0 g/dL.
- Urinary κ or λ greater than 12.0 g/24 hours.
Estimated myeloma cell mass: greater than 1.2 trillion (1012)/m2
(high burden).
The following subclassification of stages is used:
- Creatinine less than 2.0 mg/dL.
- Creatinine greater than or equal to 2.0 mg/dL.
Please refer to the NCI PDQ summary for updates on multiple myeloma

|
|
|
|
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
Application |
|
|